Lincoln Pharmaceuticals Ltd - Company Profile

Q: Who are the current directors of Lincoln Pharmaceuticals Ltd?

The current directors of Lincoln Pharmaceuticals Ltd are Munjal Mahendrabhai Patel, Darshit Ashvinkumar Shah, Trusha Atulkumar Shah, Nareshkumar Pirabhai Suthar, Seema Manubhai Mehta, Mahendrabhai Gulabdas Patel, Kishor Meghji Shah, Saurin Jagdish Bhai Parikh, Ashish Rajanikant Patel, Rajanikant Gulabdas Patel, Hashmukhbhai Ishwarlal Patel, Darshit Ashvinkumar Shah.

It is a pharma public limited company based in Ahmedabad, Gujarat, India, established in 1995.

1995 Ahmedabad, Gujarat, India Active

Last Updated: December 21, 2025

Access Report

About Lincoln Pharmaceuticals Ltd

Lincoln Pharmaceuticals Ltd, a active public limited company, was established on 20 January 1995 in Ahmedabad, Gujarat, India. Engaging in drug formulation & development within the manufacturing sector, it holds CIN: L24230GJ1995PLC024288. Registered under ROC Roc Ahmedabad. it is listed. It has an authorized capital of ₹32.00 Cr and a paid-up capital of ₹20.03 Cr.

It upholds a compliant status. In 2024, it reported revenue of ₹614.97 Cr and a net worth of ₹592.84 Cr. Employing 1,531 professional, Its leadership includes Munjal Mahendrabhai Patel (Whole-Time Director), Nareshkumar Pirabhai Suthar (Director), Seema Manubhai Mehta (Director). Past directors included Munjal Mahendrabhai Patel, Niren Atinbhai Desai, Nareshkumar Pirabhai Suthar. It holds ₹117.64 Cr open charges and ₹47.00 Cr settled loans. Its latest AGM occurred on 30 September 2025, with the balance sheet filed on 31 March 2025. It is based at Lincoln House , Behind Satyam Complex Science City Road, Sola, Ahmedabad, Gujarat, 380060.

Company Details

CIN/LLPIN
L24230GJ1995PLC024288
Registration Number
024288
Incorporation Date
20 January 1995
Authorized Capital
₹32.00 Cr
Paid-Up Capital
₹20.03 Cr
ROC Code
Roc Ahmedabad
Listing Status
Listed
Company Status
Active

Key Metrics

Authorised Capital ₹ 32.00 Cr as on 21-12-2025
Paid Up Capital ₹ 20.03 Cr as on 21-12-2025
Company Age 31 Year, 1 Month
Last Filing with ROC 31 Mar 2025
Open Charges ₹ 117.64 Cr as on 21-12-2025
Satisfied Charges ₹ 47.00 Cr as on 21-12-2025
Revenue Growth **** 15.42% (FY 2024)
Profit Growth **** 27.99% (FY 2024)
Ebitda **** 12.05% (FY 2024)
Net Worth 17.98% (FY 2024)
Total Assets **** 19.22% (FY 2024)

Comprehensive Company Insights

Explore comprehensive insights into Lincoln Pharmaceuticals Ltd — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report

Who are the key members and board of directors at Lincoln Pharmaceuticals Ltd?

Current Directors

Name	Designation	Appointment Date	Status
Munjal Mahendrabhai Patel	Whole-Time Director	14 Nov 2014	Current
Nareshkumar Pirabhai Suthar	Director	01 Apr 2024	Current
Seema Manubhai Mehta	Director	01 Apr 2024	Current
Mahendrabhai Gulabdas Patel	Managing Director	20 Jan 1995	Current
Kishor Meghji Shah	Director	16 Aug 1995	Current
Saurin Jagdish Bhai Parikh	Director	27 Mar 2018	Current

Past Directors

Name	Designation	Cessation	Status
Pramod Abcsdd	Additional Director	14 Nov 2014	Past
Pramod Abcsdd	Nodal Officer	16 Nov 2022	Past
Pramod Abcsdd	Additional Director	17 May 2024	Past
Pramod Abcsdd	Additional Director	17 May 2024	Past
Pramod Abcsdd	Director	09 Aug 2022	Past
Pramod Abcsdd	Additional Director	09 Aug 2022	Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Lincoln Pharmaceuticals.

Lincoln Pharmaceuticals Ltd, for the financial year ended 2024, experienced significant growth in revenue, with a 15.42% increase. The company also saw a substantial improvement in profitability, with a 27.99% increase in profit. The company's net worth Soared by an impressive increase of 17.98%.

Date	Amount	Transaction Name	Valuation	Lead Investors	Investors
Jul, 2021	Amount	Post-IPO - Grab	Valuation	investors	Emtek
Feb, 2021	Amount	Post-IPO - Grab	Valuation	investors	Signite Partners
Jan, 2021	Amount	Post-IPO - Grab	Valuation	investors	Hana Financial Group , GGV Capital
Feb, 2021	Amount	Post-IPO - Grab	Valuation	investors	Signite Partners

Upgrade Required

Full access to Financial is available only for users with an active Premium plan.

Key Matrics
Balance Sheet
Profit and Loss
Cash Flow
Ratios

Metrics

(FY 2023)

YOY Growth

(FY 2022)

(FY 2021)

(FY 2020)

(FY 2019)

Total Revenue

********

15.42%

*******

Revenue from Operations

*******

13.76%

*******

Total Assets

*******

19.22%

*******

Profit or Loss

*******

27.99%

*******

Net Worth

*******

17.98%

*******

EBITDA

*******

12.05%

*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Lincoln Pharmaceuticals?

In 2024, Lincoln Pharmaceuticals had a promoter holding of 49.54% and a public holding of 50.46%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Pattern (FY 2024)

Promoters: 92.83%
Public: 4.10%
Others: 3.07%

Shareholding Pattern over the Year

	FY (2024)	FY (2023)	FY (2022)	FY (2021)	FY (2020)
Promoters	92.83	94.62	94.55	94.55	94.55
Public	4.10	3.89	3.95	3.96	3.98
Others	3.07	1.49	1.50	1.49	1.47

Upgrade Required

Full access to Ownership and Shareholding Structure is available only for users with an active Premium plan.

Reveal ownership structures and financial performance - Get instant access now!

Charges (Loans)

Open Charges

₹1,176,400,000.00

Satisfied Charges

₹470,000,000.00

Charges Breakdown by Lending Institutions

State Bank Of India : 117.64 Cr

Latest Charge Details

Date	Lender	Amount	Status
03 Nov 1999	State Bank Of India	₹58.82 Cr	Open
20 Mar 1999	State Bank Of India	₹58.82 Cr	Open
24 Sep 2015	Yes Bank Limited	₹10.00 Cr	Satisfied
19 May 2015	Yes Bank Limited	₹13.00 Cr	Satisfied
29 Sep 2010	Idbi Bank Limited	₹20.00 Cr	Satisfied

Explore comprehensive loan charge details -

How Many Employees Work at Lincoln Pharmaceuticals?

Lincoln Pharmaceuticals has a workforce of 1531 employees as of Feb 25, 2025. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.

Employee Date	Number of Employees
2020	78,000
2021	80,500
2022	83,200
2023	86,000
2024	89,500
2025	92,000

Upgrade Required

Full access to People is available only for users with an active Premium plan.

Deals i

Gain comprehensive insights into the Deals and Valuation data of Lincoln Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Lincoln Pharmaceuticals's trajectory.

Rating

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Lincoln Pharmaceuticals

Recent Activity within the Organization

Annual General Meeting

Lincoln Pharmaceuticals Ltd last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records. was recorded as a recent event.
30 Sep 2025
Balance Sheet

Progress on Lincoln Pharmaceuticals Ltd has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Ahmedabad. was documented.
31 Mar 2025
Director Appointment

Progress on Nareshkumar Pirabhai Suthar was appointed as a Director was appointed as a Director on 01 Apr 2024 & has been associated with this company since 1 year 10 months . was documented.
01 Apr 2024
Director Appointment

Seema Manubhai Mehta was appointed as a Director was appointed as a Director on 01 Apr 2024 & has been associated with this company since 1 year 10 months . was recorded as a recent event.
01 Apr 2024
Director Appointment

The activity Trusha Atulkumar Shah was appointed as a Company Secretary was appointed as a Company Secretary on 16 Nov 2022 & has been associated with this company since 3 years 3 months . was completed.
16 Nov 2022
Charges

The activity A charge registered on 19 May 2015 via Charge ID 10573870 with Yes Bank Limited was fully satisfied on 29 Apr 2021. was completed.
29 Apr 2021

Explore recent activity and updates - View Recent Activity